Core Team
A world-class team combining deep expertise in neuromodulation, biomedical engineering, regulatory affairs, and Chinese market strategy.
Dr. Wei Zhang
Chief Executive Officer (CEO)
Former Senior Product Manager at Cochlear (Australia). PhD in Biomedical Engineering, University of Melbourne.
15 years in neuromodulation; led TGA and FDA registrations for three implantable devices; expert in Australian Medicare reimbursement pathways.
Prof. Jian Li
Chief Scientific Officer (CSO)
Principal Investigator at the Florey Institute of Neuroscience and Mental Health; IEEE Senior Member.
Specializes in endovascular electrode signal processing; published over 20 papers in Nature sub-journals; founder of the NeuralStent™ algorithm.
Dr. Chen Wang
Chief Technology Officer (CTO)
Former Chief Engineer for Micro-Nano Sensors at Huawei's 2012 Laboratory.
Responsible for ASIC chip design and miniaturization packaging; extended implant battery life from 3 to 10 years.
Dr. Ming Zhao
Clinical & Regulatory Director (China)
Former Distinguished Expert at the Center for Medical Device Evaluation (CMDE) of the NMPA.
Oversees the Boao Lecheng Real-World Data Study project, establishing a fast-track channel for "Australian Clinical Trials to Chinese Market Launch."